Objective: To investigate the prevalence of anti-C-reactive protein (CRP) autoantibodies in patients with systemic lupus erythematosus (SLE) and non-SLE patients with persistent …

2005年11月16日 · The database we used to address this question consisted of 1051 consecutive pts with untreated AML (APL excepted) or high-risk MDS (> 10% blasts) considered for …

2005年12月13日 · Similarities were found between elevated levels of hs-CRP and the presence of antiphospholipid antibodies (aPL) for the pathology of thrombosis. Both hs-CRP and aPL …

High-sensitive C-reactive protein (hs-CRP) is a marker of inflammation which has been shown in several prospective studies to independently predict myocardial infarction, stroke and …

2004年11月16日 · High-sensitive C-reactive protein (hs-CRP) is a marker of inflammation which has been shown in several prospective studies to predict independently myocardial infarction, …

2012年12月8日 · Antiphospholipid (aPL) syndrome (APS) is an acquired autoimmune thrombotic tendency in which patients have circulating antibodies (Abs) against plasma proteins that bind …

2005年11月16日 · For many years response to induction therapy for AML was classified as CR or no CR. Recently, responses less than CR, e.g. CR with incomplete platelet recovery (CRp), …

2005年12月1日 · Patients with antiphospholipid antibodies (aPL) are at increased risk of recurrent thromboembolic events, but the possibility of predicting this risk seems rather limited. …

Anti-CRP antibodies occurred markedly more frequently in patients with thrombosis or fetal loss—features of the antiphospholipid syndrome—than in asymptomatic aPL carriers, in both …

Complement activation and low complement levels are common in systemic lupus erythematosus (SLE). Antiphospholipid antibodies (aPL) are found in about 30-40% of patients with SLE. This …